Simplex Trading’s Novelion Therapeutics NVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-298
Closed -$88K – 8308
2018
Q3
$88K Buy
+298
New +$1.06K ﹤0.01% 4573
2017
Q4
– Sell
-211
Closed -$3K – 7110
2017
Q3
$3K Sell
211
-150
-42% -$1.2K ﹤0.01% 4942
2017
Q2
$9K Buy
+361
New +$3.48K ﹤0.01% 4109

Other funds holding NVLN

Simplex Trading's NVLN Position: Q3 2019 in Review

Simplex Trading sold out of Novelion Therapeutics (NVLN) in Q3 2019, closing a stake of 10,000 shares — an estimated $7K sold.

Simplex Trading first reported a position in NVLN in Q4 2016 and held it in 5 quarters. The position peaked at $73K in Q1 2017. 31 funds tracked by Wall St. Rank hold NVLN as of Q3 2019.

  • Simplex Trading reported no remaining Novelion Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Simplex Trading sold 10,000 Novelion Therapeutics shares in Q3 2019, an estimated $7K.
  • Simplex Trading first reported a position in Novelion Therapeutics in Q4 2016 and held it in 5 quarters.
  • Simplex Trading's Novelion Therapeutics position peaked at $73K in Q1 2017.
  • 31 funds tracked by Wall St. Rank held Novelion Therapeutics as of Q3 2019.

Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.